Abstract
When S phase lymphocytes were treated for various times with high doses of ConA, we observed that labelled precursor incorporation into DNA was suppressed. This inhibition is characterized by its rapid onset, its lectin dose dependence and reversibility by α-methyl-mannoside. The uptake of labelled desoxyribonucleoside precursors is not modified by the treatment. The nucleoside kinase activity tested on cellular extracts showed a slight but significant decrease. However, the fact that the specific activity of newly replicated DNA was not modified indicates that the DNA labelling suppression is not a direct consequence of alterations in pathways of labelled DNA precursor synthesis. The available ATP pool in treated cells decreased by 25% after 30 min and near 50% after 1 h. The decrease in DNA labelling observed is related to a decrease in the overall rate of DNA synthesis. From density shift analysis of very large DNA molecules labelled by [ 125I]UdR BUdR (a large part of a cluster of replicons), as well as velocity sedimentation analysis of pulse-chased molecules, we have demonstrated that ( i) the DNA elongation within active replicons is not blocked; ( ii) the rate of assembly of newly replicated DNA fragments (replicons) seems to be unmodified. Consequently, the initiations of adjacent replicons in operating clusters are not affected. However, the number of clusters which start their replication by initiation of new replicons is greatly reduced after 1 h of ConA treatment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.